He said Curative has “captured up to 10% of the daily COVID-19 test samples across the United States” in its brief nine-month history.
The company’s CEO, Fred Turner, is a 26-year-old, Oxford-educated science and technology prodigy who in September 2020 told the scientific trade journal Cell Systems that he dropped out of college to pursue his interests, and that he started and pivoted two biotechnology companies in the Silicon Valley prior to starting Curative. Lucky few hit the COVID-19 vaccine jackpot for rare extra doses.Coronavirus vaccine rollout in LA County leaving many frustrated.LA County will replace COVID-19 tests made by San Dimas-based Curative at pop-up testing sites.Curative coronavirus tests will still be used in Riverside County, despite accuracy concerns.FDA warns of false results from San Dimas-based Curative coronavirus tests.began its venture improving on sepsis testing, but when the pandemic struck, it shifted its focus to COVID-19 testing, producing an oral swab test that could be self-administered in 20 seconds. Meteoric riseįounded in the Silicon Valley’s Menlo Park in January 2020, Curative Inc. “That’s 92,000 people who otherwise might have not known, might have been spreading and might have seen this explode even more,” he said at a news conference on Jan. Mayor Eric Garcetti defended the city’s decision to continue working working with Curative, as its test has been able to detect positive results from 92,000 asymptomatic people, which, he said, would have otherwise gone undetected and further spread the virus. “Bottom line is that the current test works fine.”ĭespite concerns of accuracy, L.A. “It’s one of the most popular tests for a reason with over 10,000 sites across the country,” Klausner said in a phone interview Wednesday, Jan. While the warning reminds people to follow test instructions carefully and be observed, Klausner said, the FDA only authorizes the test, it does not regulate a physician’s or nurse’s practice. Jeffrey Klausner, Curative’s acting medical director, described the FDA notice about Curative’s test as “confusing” and did not provide any data to support its stance. Monahan also stressed that the FDA notice did “not raise any doubts about the accuracy of a positive test result,” and that the potential concern only relates to negative test results.ĭr. It is a problem for all coronavirus tests.” “This may happen more often when people are without symptoms of the coronavirus disease,” Monahan said in his memo. Test effectiveness praisedĬurative and its partners say the test is highly effective when administered according to label, as the FDA instructed in its public safety alert. On Jan.15, Curative launched its first company-run vaccination site at El Camino College in Torrance, and will soon open another test site in Palm Desert, a company spokesman said.
While the alert ended the company’s partnerships with Los Angeles and Sonoma counties and Congress, Curative was undeterred, maintaining partnerships with 14 other states, cities and counties, and expanding its services to include COVID-19 vaccination.
Additionally, the FDA asked that people taking the self-administered test be observed by a health-care worker. The test, which uses a technique known as polymerase chain reaction, or PCR, requires people to cough three times and use a cotton swab to rub along their gum line and tongue. 4 safety alert by the Food and Drug Administration pushed Curative into the national spotlight when it warned that the company’s test could produce false negative results if not properly administered.
0 kommentar(er)
